Cancer Research Grants  Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhou, B.
Right arrow Articles by Zhang, X. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, B.
Right arrow Articles by Zhang, X. A.
[Cancer Research 64, 7455-7463, October 15, 2004]
© 2004 American Association for Cancer Research


Regular Articles

The Palmitoylation of Metastasis Suppressor KAI1/CD82 Is Important for Its Motility- and Invasiveness-Inhibitory Activity

Bin Zhou1, Li Liu1, Muralidhar Reddivari1 and Xin A. Zhang1,2

1 Vascular Biology Center and Department of Medicine and 2 Department of Molecular Science, University of Tennessee Health Science Center, Memphis, Tennessee

The cancer metastasis suppressor protein KAI1/CD82 is a member of the tetraspanin superfamily. Recent studies have demonstrated that tetraspanins are palmitoylated and that palmitoylation contributes to the organization of tetraspanin webs or tetraspanin-enriched microdomains. However, the effect of palmitoylation on tetraspanin-mediated cellular functions remains obscure. In this study, we found that tetraspanin KAI1/CD82 was palmitoylated when expressed in PC3 metastatic prostate cancer cells and that palmitoylation involved all of the cytoplasmic cysteine residues proximal to the plasma membrane. Notably, the palmitoylation-deficient KAI1/CD82 mutant largely reversed the wild-type KAI1/CD82’s inhibitory effects on migration and invasion of PC3 cells. Also, palmitoylation regulates the subcellular distribution of KAI1/CD82 and its association with other tetraspanins, suggesting that the localized interaction of KAI1/CD82 with tetraspanin webs or tetraspanin-enriched microdomains is important for KAI1/CD82’s motility-inhibitory activity. Moreover, we found that KAI1/CD82 palmitoylation affected motility-related subcellular events such as lamellipodia formation and actin cytoskeleton organization and that the alteration of these processes likely contributes to KAI1/CD82’s inhibition of motility. Finally, the reversal of cell motility seen in the palmitoylation-deficient KAI1/CD82 mutant correlates with regaining of p130CAS-CrkII coupling, a signaling step important for KAI1/CD82’s activity. Taken together, our results indicate that palmitoylation is crucial for the functional integrity of tetraspanin KAI1/CD82 during the suppression of cancer cell migration and invasion.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
R. Bari, Y. H. Zhang, F. Zhang, N. X. Wang, C. S. Stipp, J. J. Zheng, and X. A. Zhang
Transmembrane Interactions Are Needed for KAI1/CD82-Mediated Suppression of Cancer Invasion and Metastasis
Am. J. Pathol., February 1, 2009; 174(2): 647 - 660.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
J. Ren, L. Wen, X. Gao, C. Jin, Y. Xue, and X. Yao
CSS-Palm 2.0: an updated software for palmitoylation sites prediction
Protein Eng. Des. Sel., November 1, 2008; 21(11): 639 - 644.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
C. Sharma, X. H. Yang, and M. E. Hemler
DHHC2 Affects Palmitoylation, Stability, and Functions of Tetraspanins CD9 and CD151
Mol. Biol. Cell, August 1, 2008; 19(8): 3415 - 3425.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. S. Stowers and E. Y. Isacoff
Drosophila Huntingtin-Interacting Protein 14 Is a Presynaptic Protein Required for Photoreceptor Synaptic Transmission and Expression of the Palmitoylated Proteins Synaptosome-Associated Protein 25 and Cysteine String Protein
J. Neurosci., November 21, 2007; 27(47): 12874 - 12883.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
O. V. Kovalenko, X. H. Yang, and M. E. Hemler
A Novel Cysteine Cross-linking Method Reveals a Direct Association between Claudin-1 and Tetraspanin CD9
Mol. Cell. Proteomics, November 1, 2007; 6(11): 1855 - 1867.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. S. Schrecengost, R. B. Riggins, K. S. Thomas, M. S. Guerrero, and A. H. Bouton
Breast Cancer Antiestrogen Resistance-3 Expression Regulates Breast Cancer Cell Migration through Promotion of p130Cas Membrane Localization and Membrane Ruffling
Cancer Res., July 1, 2007; 67(13): 6174 - 6182.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Mazurov, G. Heidecker, and D. Derse
The Inner Loop of Tetraspanins CD82 and CD81 Mediates Interactions with Human T Cell Lymphotrophic Virus Type 1 Gag Protein
J. Biol. Chem., February 9, 2007; 282(6): 3896 - 3903.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Gesierich, I. Berezovskiy, E. Ryschich, and M. Zoller
Systemic Induction of the Angiogenesis Switch by the Tetraspanin D6.1A/CO-029.
Cancer Res., July 15, 2006; 66(14): 7083 - 7094.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. H. Yang, O. V. Kovalenko, T. V. Kolesnikova, M. M. Andzelm, E. Rubinstein, J. L. Strominger, and M. E. Hemler
Contrasting Effects of EWI Proteins, Integrins, and Protein Palmitoylation on Cell Surface CD9 Organization
J. Biol. Chem., May 5, 2006; 281(18): 12976 - 12985.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.